Floor & Decor Holdings Inc (NYSE:FND) – Equities researchers at Jefferies Financial Group raised their Q4 2019 EPS estimates for Floor & Decor in a report released on Friday, August 2nd, according to Zacks Investment Research. Jefferies Financial Group analyst J. Matuszewski now anticipates that the company will post earnings of $0.24 per share for the quarter, up from their prior estimate of $0.21. Jefferies Financial Group also issued estimates for Floor & Decor’s Q4 2020 earnings at $0.36 EPS.

Enphase Energy Inc (NASDAQ:ENPH) – Research analysts at Oppenheimer raised their Q3 2019 earnings estimates for shares of Enphase Energy in a research report issued on Wednesday, July 31st, according to Zacks Investment Research. Oppenheimer analyst C. Rusch now anticipates that the semiconductor company will post earnings of $0.23 per share for the quarter, up from their previous forecast of $0.13. Oppenheimer has a “Outperform” rating and a $26.00 price objective on the stock. Oppenheimer also issued estimates for Enphase Energy’s Q4 2019 earnings at $0.25 EPS, FY2019 earnings at $0.60 EPS, FY2020 earnings at $0.97 EPS and FY2021 earnings at $1.20 EPS.

The Coca-Cola Co (NYSE:KO) – Jefferies Financial Group boosted their Q4 2019 earnings estimates for shares of The Coca-Cola in a report issued on Tuesday, July 23rd, Zacks Investment Research reports. Jefferies Financial Group analyst K. Grundy now expects that the company will post earnings per share of $0.45 for the quarter, up from their previous estimate of $0.43.

Agenus Inc (NASDAQ:AGEN) – Research analysts at B. Riley issued their Q3 2019 earnings estimates for shares of Agenus in a research report issued on Wednesday, August 14th. B. Riley analyst H. Polishetty anticipates that the biotechnology company will earn ($0.52) per share for the quarter. B. Riley has a “Buy” rating and a $5.00 price objective on the stock. B. Riley also issued estimates for Agenus’ Q4 2019 earnings at ($0.30) EPS, FY2019 earnings at ($1.06) EPS, FY2020 earnings at ($0.98) EPS, FY2021 earnings at ($0.67) EPS, FY2022 earnings at ($0.56) EPS and FY2023 earnings at ($0.31) EPS.

ASGN Inc (NYSE:ASGN) – Equities researchers at William Blair decreased their Q3 2019 earnings per share (EPS) estimates for ASGN in a note issued to investors on Thursday, July 25th, Zacks Investment Research reports. William Blair analyst T. Mchugh now forecasts that the business services provider will earn $1.23 per share for the quarter, down from their prior estimate of $1.27. William Blair also issued estimates for ASGN’s FY2019 earnings at $4.60 EPS, Q1 2020 earnings at $1.04 EPS, Q2 2020 earnings at $1.29 EPS, Q3 2020 earnings at $1.38 EPS and FY2020 earnings at $5.13 EPS.

First Financial Bankshares Inc (NASDAQ:FFIN) – Stock analysts at SunTrust Banks boosted their Q3 2019 earnings estimates for shares of First Financial Bankshares in a research note issued on Monday, July 22nd, according to Zacks Investment Research. SunTrust Banks analyst J. Demba now anticipates that the bank will earn $0.31 per share for the quarter, up from their prior forecast of $0.30. SunTrust Banks also issued estimates for First Financial Bankshares’ Q2 2020 earnings at $0.31 EPS.

Universal Display Co. (NASDAQ:OLED) – Research analysts at Gabelli upped their FY2019 EPS estimates for shares of Universal Display in a report released on Monday, August 5th. Gabelli analyst H. Susanto now forecasts that the semiconductor company will post earnings per share of $2.60 for the year, up from their previous estimate of $2.30.

Hill-Rom Holdings, Inc. (NYSE:HRC) – Equities researchers at KeyCorp issued their FY2021 earnings per share estimates for shares of Hill-Rom in a research note issued to investors on Sunday, August 4th. KeyCorp analyst M. Mishan forecasts that the medical technology company will post earnings per share of $6.25 for the year. KeyCorp currently has a “Overweight” rating and a $125.00 price objective on the stock.

Agile Therapeutics Inc (NASDAQ:AGRX) – Equities researchers at Oppenheimer lowered their FY2022 earnings per share (EPS) estimates for shares of Agile Therapeutics in a research report issued on Monday, August 5th. Oppenheimer analyst L. Gershell now expects that the specialty pharmaceutical company will post earnings of $1.34 per share for the year, down from their prior forecast of $1.38. Oppenheimer has a “Outperform” rating and a $5.00 price target on the stock. Oppenheimer also issued estimates for Agile Therapeutics’ FY2023 earnings at $1.71 EPS.

Viper Energy Partners LP (NASDAQ:VNOM) – Equities researchers at Capital One Financial dropped their Q3 2019 earnings per share (EPS) estimates for shares of Viper Energy Partners in a report released on Monday, August 5th. Capital One Financial analyst K. May now expects that the oil and gas producer will post earnings per share of $0.07 for the quarter, down from their prior forecast of $0.09. Capital One Financial has a “Overweight” rating and a $37.00 price target on the stock. Capital One Financial also issued estimates for Viper Energy Partners’ Q4 2019 earnings at $0.22 EPS and Q4 2020 earnings at $0.17 EPS.